Advanced glycation end products (AGE) in the pathogenesis of ischaemic cardiomyopathy in diabetic patients - Preliminary report

Kardiochirurgia i Torakochirurgia Polska

Volumn 5, Issue 1, 2008, Pages 56-63

  Nozyński, Jerzy K ^a   Zakliczyński, Michał ^a   Konecka Mrówka, Dominika ^a   Nikiel, Barbara ^b   Młynarczyk Liszka, Joanna ^b   Lange, Dariusz ^b   Maruszewski, Marcin ^a   Zembala, Marian ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Advanced glycation end products; Heart failure; Immunohistochemistry; Ischaemic cardiomyopathy

Indexed keywords

EID: 60649084228     PISSN: 17315530     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, Dobbels F, Rahmel AO, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 2007;26:782-795. (Pubitemid 47199080)
2. Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N (epsilon) - (carboxymethyl) lysine in human tissues in diabetes and aging. J Clin Invest 1997;99:457-468. (Pubitemid 27414803)
3. Goh SY, Cooper ME. The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008; Jan 8 [Epub ahead of print].
4. Giardino I, Edelstein D, Brownlee M. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J Clin Invest 1994;94:110-117.
5. Peppa M, Uribarri J, Cai W, Lu M, Vlassara H. Glycoxidation and inflammation in renal failure patients. Am J Kidney Dis 2004;43:6690-695.
6. Vlassara H. Advanced glycation end-products and atherosclerosis. Ann Med 1996;28:419-426. (Pubitemid 26380001)
7. Vlassara H, Palace MR. Glycoxidation: the menace of diabetes and aging. Mt Sinai J Med 2003;70:232-241. (Pubitemid 37321701)
8. Haitoglou CS, Tsilibary EC, Brownlee M, Charonis AS. Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen. J Biol Chem 1992;267:12404-12407.
9. Throckmorton DC, Brogden AP, Min B, Rasmussen H, Kashgarian M. PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int 1995;48:111-117.
10. Forbes JM, Cooper ME, Oldfield MD, Thomas MC. Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol 2003;14(8 Suppl 3): S254-S258. (Pubitemid 36903936)
11. Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J 2003;17:1762-1764.
12. Twigg SM, Cao Z, MCLennan S V, Burns WC, Brammar G, Forbes JM, Cooper ME. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 2002;143:4907-4915. (Pubitemid 35397630)
13. Berg TJ, Snorgaard O, Faber J, Torjesen PA, Hildebrandt P, Mehlsen J, Hanssen K F. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care 1999;22:1186-1190. (Pubitemid 29293975)
14. Lapolla A, Piarulli F, Sartore G, Ceriello A, Ragazzi E, Reitano R, Baccarin L, Laverda B, Fedele D. Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. Diabetes Care 2007;530:6670-676.
15. Yoshida N, Okumura K, Aso Y. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes. Metabolism 2005;54:345-350. (Pubitemid 40250094)
16. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986;232:1629-1632. (Pubitemid 16095602)
17. Cooper ME. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease. Am J Hypertens 2004;17:31S-38S. (Pubitemid 39647569)
18. Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen K F. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care 1999;22:1543-1548. (Pubitemid 29418253)
19. Virmani R, Burke AP, Kolodgie F. Morphological characteristics of coronary atherosclerosis in diabetes mellitus. Can J Cardiol 2006;22(Suppl B): 81B-84B.
20. Yan SF, Ramasamy R, Bucciarelli LG, Wendt T, Lee LK, Hudson BI, Stern DM, Lalla E, DU Yan S, Rong LL, Naka Y, Schmidt AM. RAGE and its ligands: a lasting memory in diabetic complications? Diab Vasc Dis Res 2004;1:10-20.
21. Yamada K, Miyahara Y, Hamaguchi K, Nakayama M, Nakano H, Nozaki O, Miura Y, Suzuki S, Tuchida H, Mimura N. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure. Clin Nephrol 1994;42:354-361.
22. Shikata K, Makino H, Sugimoto H, Kushiro M, Ota K, Akiyama K, Araki N, Horiuchi S, Ota Z. Localization of advanced glycation endproducts in the kidney of experimental diabetic rats. J Diabetes Complications 1995;9:269-271.
23. Makino H, Shikata K, Hironaka K, Kushiro M, Yamasaki Y, Sugimoto H, Ota Z, Araki N, Horiuchi S. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int 1995;48:517-526.
24. Sakata N, Imanaga Y, Meng J, Tachikawa Y, Takebayashi S, Nagai R, Horiuchi S, Itabe H, Takano T. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions. Atherosclerosis 1998;141:61-75. (Pubitemid 28539417)
25. Yoshida S, Yamada K, Hamaguchi K, Nishimura M, Hatakeyama E, Tsuchida H, Sakamoto K, Kashiwabara H, Yokoyama T, Ikeda K, Horiuchi S. Immuno-histochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation. Clin Nephrol 1998;49:273-280. (Pubitemid 28220980)
26. Cilingiroglu M, Elliott J, Patel D, Tio F, Matthews H, McCasland M, Trauthen B, Elicker J, Bailey SR. Long-term effects of novel biolimus eluting DEVAX AXXESS plus nitinol self-expanding stent in a porcine coronary model. Catheter Cardiovasc Interv 2006;68:271-279. (Pubitemid 44167682)
27. Petrova R, Yamamoto Y, Muraki K, Yonekura H, Sakurai S, Watanabe T, Li H, Takeuchi M, Makita Z, Kato I, Takasawa S, Okamoto H, Imaizumi Y, Yamamoto H. Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes. J Mol Cell Cardiol 2002;34:1425-1431. (Pubitemid 35244419)
28. Naito Z, Takashi E, Xu G, Ishiwata T, Teduka K, Yokoyama M, Yamada N, Sugisaki Y, Asano G. Different influences of hyperglycemic duration on phosphorylated extracellular signal-regulated kinase 1/2 in rat heart. Exp Mol Pathol 2003;74:23-32. (Pubitemid 41264487)
29. Lange D, Zembala M Jr, Nożyński J, Śnietura M, Zembala M. Makroangiopatia cukrzycowa u chorych poddanych zabiegowi pomostowania tȩtnic wieńcowych. Kardiochir Torakochir Pol 2004;1:185-192.
30. Sato Y, Kondo T, Ohshima T. Estimation of age of human cadavers by immunohistochemical assessment of advanced glycation end products in the hippocampus. Histopathology 2001;38:217-220. (Pubitemid 32862730)
31. Okamoto T, Yamagishi S, Inagaki Y, Amano S, Koga K, Abe R, Takeuchi M, Ohno S, Yoshimura A, Makita Z. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin. FASEB J 2002;16:1928-1930.
32. Okamoto T, Tanaka S, Stan AC, Koike T, Kase M, Makita Z, Sawa H, Nagashima K. Advanced glycation end products induce angiogenesis in vivo. Microvasc Res 2002;563:186-195. (Pubitemid 34971635)
33. Kocica MJ, Corno AF, Lackovic V, Kanjuh VI. The helical ventricular myocardial band of Torrent-Guasp. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2007;52-60. (Pubitemid 46552900)
34. Boulton AJ. Diabetic neuropathy: classification, measurement and treatment. Curr Opin Endocrinol Diabetes Obes 2007;14:141-145. (Pubitemid 46363295)
35. Heidland A, Sebeková K, Frangiosa A, De Santo LS, Cirillo M, Rossi F, Cotrufo M, Perna A, Klassen A, Schinzel R, De Santo NG. Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation. Heart 2004;90:1269-1274. (Pubitemid 39433984)